Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo.
Eur J Med Chem. 2024 Jan 15;264:116014. doi: 10.1016/j.ejmech.2023.116014. Epub 2023 Dec 1.
Eur J Med Chem. 2024.
PMID: 38061230
Free article.
Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers.
Kuchukulla RR, Hwang I, Park SW, Moon S, Kim SH, Kim S, Chung HW, Ji MJ, Park HM, Kong G, Hur W.
Kuchukulla RR, et al.
Pharmaceuticals (Basel). 2022 Aug 23;15(9):1041. doi: 10.3390/ph15091041.
Pharmaceuticals (Basel). 2022.
PMID: 36145262
Free PMC article.
Item in Clipboard
Recent Advances in Multicomponent Reactions with Organic and Inorganic Sulfur Compounds.
Tang Q, Yin X, Kuchukulla RR, Zeng Q.
Tang Q, et al. Among authors: kuchukulla rr.
Chem Rec. 2021 Apr;21(4):893-905. doi: 10.1002/tcr.202100026. Epub 2021 Mar 18.
Chem Rec. 2021.
PMID: 33734557
Review.
Item in Clipboard
Cite
Cite